[go: up one dir, main page]

DE60316423D1 - Tyrosinkinase-hemmer - Google Patents

Tyrosinkinase-hemmer

Info

Publication number
DE60316423D1
DE60316423D1 DE60316423T DE60316423T DE60316423D1 DE 60316423 D1 DE60316423 D1 DE 60316423D1 DE 60316423 T DE60316423 T DE 60316423T DE 60316423 T DE60316423 T DE 60316423T DE 60316423 D1 DE60316423 D1 DE 60316423D1
Authority
DE
Germany
Prior art keywords
compounds
tyrosine kinase
kinase inhibitor
present
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60316423T
Other languages
English (en)
Other versions
DE60316423T2 (de
Inventor
B Wesley Trotter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE60316423D1 publication Critical patent/DE60316423D1/de
Publication of DE60316423T2 publication Critical patent/DE60316423T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Ophthalmology & Optometry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60316423T 2002-04-12 2003-04-08 Tyrosinkinase-hemmer Expired - Lifetime DE60316423T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37223202P 2002-04-12 2002-04-12
US372232P 2002-04-12
PCT/US2003/012457 WO2003086315A2 (en) 2002-04-12 2003-04-08 Tyrosine kinase inhibitors

Publications (2)

Publication Number Publication Date
DE60316423D1 true DE60316423D1 (de) 2007-10-31
DE60316423T2 DE60316423T2 (de) 2008-06-12

Family

ID=29250816

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60316423T Expired - Lifetime DE60316423T2 (de) 2002-04-12 2003-04-08 Tyrosinkinase-hemmer

Country Status (9)

Country Link
US (1) US7371754B2 (de)
EP (1) EP1496907B1 (de)
JP (1) JP4475389B2 (de)
AT (1) ATE373662T1 (de)
AU (1) AU2003223689B2 (de)
CA (1) CA2480758A1 (de)
DE (1) DE60316423T2 (de)
ES (1) ES2292956T3 (de)
WO (1) WO2003086315A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60321330D1 (de) 2002-04-12 2008-07-10 Merck & Co Inc Tyrosinkinase-hemmer
EP1496897A4 (de) * 2002-04-12 2006-05-10 Merck & Co Inc Tyrosinkinase-hemmer
EP1993292B1 (de) 2006-03-09 2013-05-15 NEC Corporation Verfahren und vorrichtung für dynamische bildkodierung und programm damit
US8530475B2 (en) 2006-05-18 2013-09-10 Janssen Pharmaceutica Nv Bridged aryl piperazines derivatives useful for the treatment of CNS, GI-urinary and reproductive disorders
US8642067B2 (en) 2007-04-02 2014-02-04 Allergen, Inc. Methods and compositions for intraocular administration to treat ocular conditions
CN117257805B (zh) * 2023-11-10 2024-03-12 中山大学附属第八医院(深圳福田) 核苷类逆转录酶抑制剂在制备抗血管钙化药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4332810A (en) 1981-01-26 1982-06-01 Merck & Co., Inc. N-(Substituted)-2,5-ethano-8-hydroxy (or methoxy)-1,2,3,4,5,6-hexahydro-3 (or 4)-benzazocine centrally-acting analgesics
DK1319000T3 (da) 2000-09-20 2009-02-16 Aprea Ab Anvendelse af 1-azabicyclo(2,2,2)oktan-3-on-derivater til behandling af cancertumorer
GB0110797D0 (en) * 2001-05-02 2001-06-27 Celltech R&D Ltd Chemical compounds
DE60321330D1 (de) 2002-04-12 2008-07-10 Merck & Co Inc Tyrosinkinase-hemmer
EP1496897A4 (de) 2002-04-12 2006-05-10 Merck & Co Inc Tyrosinkinase-hemmer

Also Published As

Publication number Publication date
JP2005528387A (ja) 2005-09-22
WO2003086315A3 (en) 2004-01-08
ES2292956T3 (es) 2008-03-16
CA2480758A1 (en) 2003-10-23
EP1496907A2 (de) 2005-01-19
AU2003223689A1 (en) 2003-10-27
WO2003086315A2 (en) 2003-10-23
US20050227988A1 (en) 2005-10-13
DE60316423T2 (de) 2008-06-12
EP1496907B1 (de) 2007-09-19
AU2003223689B2 (en) 2009-08-20
US7371754B2 (en) 2008-05-13
JP4475389B2 (ja) 2010-06-09
ATE373662T1 (de) 2007-10-15
EP1496907A4 (de) 2006-05-10

Similar Documents

Publication Publication Date Title
ATE482938T1 (de) Tyrosinkinaseinhibitoren
WO2004014300A3 (en) Tyrosine kinase inhibitors
WO2003035615A3 (en) Tyrosine kinase inhibitors
DK1362047T3 (da) Indazolylsubstituerede pyrrolinforbindelser som kinaseinhibitorer
WO2004031401A3 (en) Novel tyrosine kinases inhibitors
AU2001241798A1 (en) 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
WO2004096795A3 (en) C-fms kinase inhibitors
WO2003035616A3 (en) Tyrosine kinase inhibitors
CA2400447A1 (en) Kinase inhibitors
WO2003035619A8 (en) Tyrosine kinase inhibitors
SG132683A1 (en) Imidazopyrazine tyrosine kinase inhibitors
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
WO2001019828A3 (en) Kinase inhibitors as therapeutic agents
IL163781A0 (en) Purine derivatives as kinase inhibitors
MY139689A (en) Imidazotriazines as protein kinase inhibitors
WO2003035614A3 (en) Tyrosine kinase inhibitors
IL163777A0 (en) Kinase inhibitors
WO2006047479A3 (en) C-fms kinase inhibitors
MXPA05013076A (es) Compuestos de isoindolina-1-ona como inhibidores de cinasa.
WO2006047503A3 (en) Inhibitors of c-fms kinase
AU2001230395A1 (en) Use of cox-2 inhibitors as gastroprokinetics
DE60316423D1 (de) Tyrosinkinase-hemmer
TW200628153A (en) Novel compounds
DE60321330D1 (de) Tyrosinkinase-hemmer
WO2005009373A3 (en) Tyrosine kinase inhibitors

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MERCK SHARP & DOHME CORP., RAHWAY, N.J., US

8328 Change in the person/name/address of the agent

Representative=s name: MARKS & CLERK (LUXEMBOURG) LLP, LUXEMBOURG, LU